Subscribe

CRI to Host Second Annual Spanish-Language Virtual Immunotherapy patient Summit

The free online event will connect cancer patients and caregivers with the latest promising research findings shared...

CRI Names Newest Class of STARs

Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer...

Cellular Cancer Immunotherapy Therapy Landscape Update

Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends...

10th Annual Cancer Immunotherapy Month™

Awareness and educational program offerings for cancer patients and caregivers about the latest advances in cancer immunotherapy...

First Patients in Ovarian Cancer Trial

First patients dosed in phase 2 platform clinical trial testing novel immunotherapy combinations in highly malignant ovarian...

PD1/PDL1 Immuno-Oncology Landscape Trends

CRI’s latest analysis of the PD1/PDL1 immuno-oncology landscape confirms trends in trial design and patient enrollment, points...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.